More on Novartis
- Novartis' Pipeline Building Continues, Pelacarsen Readout Coming Soon
- Novartis: 'Hold' On Continued Generic Erosion And Need For H2 2026 Catalysts
- Novartis Plays Long Game With Antares Deal - Meaning Near-Term Upside Unlikely
- Novartis beats top-line and bottom-line estimates; reaffirms FY26 outlook
- Novartis Q2 2026 Earnings Preview